These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18656197)

  • 61. The role of endothelium in cardiovascular homeostasis and diseases.
    Rubanyi GM
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S1-14. PubMed ID: 7523767
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The endothelium in health and disease--a target for therapeutic intervention.
    Triggle CR; Hollenberg M; Anderson TJ; Ding H; Jiang Y; Ceroni L; Wiehler WB; Ng ES; Ellis A; Andrews K; McGuire JJ; Pannirselvam M
    J Smooth Muscle Res; 2003 Dec; 39(6):249-67. PubMed ID: 15048017
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolic regulation and dysregulation of endothelial small conductance calcium activated potassium channels.
    Kant S; Sellke F; Feng J
    Eur J Cell Biol; 2022 Apr; 101(2):151208. PubMed ID: 35151983
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins.
    Giles TD; Sander GE; Nossaman BD; Kadowitz PJ
    J Clin Hypertens (Greenwich); 2012 Apr; 14(4):198-205. PubMed ID: 22458740
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Endothelium-dependent hyperpolarization: a role in the control of vascular tone.
    Garland CJ; Plane F; Kemp BK; Cocks TM
    Trends Pharmacol Sci; 1995 Jan; 16(1):23-30. PubMed ID: 7732600
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor.
    Shimokawa H
    Pflugers Arch; 2010 May; 459(6):915-22. PubMed ID: 20140449
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vascular endothelium: vasoactive mediators.
    Vanhoutte PM; Mombouli JV
    Prog Cardiovasc Dis; 1996; 39(3):229-38. PubMed ID: 8970575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An overview of endothelium-derived hyperpolarising factor (EDHF) in normal and compromised pregnancies.
    Gillham JC; Kenny LC; Baker PN
    Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):2-7. PubMed ID: 12818435
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Myoendothelial electrical coupling in arteries and arterioles and its implications for endothelium-derived hyperpolarizing factor.
    Coleman HA; Tare M; Parkington HC
    Clin Exp Pharmacol Physiol; 2002 Jul; 29(7):630-7. PubMed ID: 12060109
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Therapeutic target for endothelium-derived hyperpolarizing factor signaling in diabetic vascular complication].
    Matsumoto T
    Yakugaku Zasshi; 2010 Jun; 130(6):777-84. PubMed ID: 20519855
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the 'endothelium-derived hyperpolarizing factor'.
    Dessy C; Feron O; Balligand JL
    Pflugers Arch; 2010 May; 459(6):817-27. PubMed ID: 20339866
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of the endothelium in the genesis of cardiovascular disease.
    Angus JA
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):S16-22. PubMed ID: 8886508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Endothelium-dependent vasoactive modulation in the ophthalmic circulation.
    Haefliger IO; Flammer J; Bény JL; Lüscher TF
    Prog Retin Eye Res; 2001 Mar; 20(2):209-25. PubMed ID: 11173252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The endothelium-derived relaxing factor.
    Jackson WF
    J Reconstr Microsurg; 1989 Jul; 5(3):263-71. PubMed ID: 2671352
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanoreception by the endothelium: mediators and mechanisms of pressure- and flow-induced vascular responses.
    Rubanyi GM; Freay AD; Kauser K; Johns A; Harder DR
    Blood Vessels; 1990; 27(2-5):246-57. PubMed ID: 2242445
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Back to the salt mines-- endothelial dysfunction in hypertension and compensatory role of endothelium-derived hyperpolarizing factor (EDHF).
    Katusic ZS
    J Physiol; 2002 Aug; 543(Pt 1):1. PubMed ID: 12181276
    [No Abstract]   [Full Text] [Related]  

  • 77. Endothelium, vasoactive factors and inflammation. Abstracts of the 5th International EDHF (Endothelium-Derived Hyperpolarizing Factor) Symposium. June 24-27, 2008, Tampere, Finland.
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102 Suppl 1():1-57. PubMed ID: 19522887
    [No Abstract]   [Full Text] [Related]  

  • 78. The paracrine control of vascular motion. A historical perspective.
    Nava E; Llorens S
    Pharmacol Res; 2016 Nov; 113(Pt A):125-145. PubMed ID: 27530204
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vascular cytochrome P450 in the regulation of renal function and vascular tone: EDHF, superoxide anions and blood pressure.
    Fleming I; Busse R
    Nephrol Dial Transplant; 2001 Jul; 16(7):1309-11. PubMed ID: 11427614
    [No Abstract]   [Full Text] [Related]  

  • 80. Regulation of vascular function and blood pressure by circadian variation in redox signalling.
    Rodrigo GC; Herbert KE
    Free Radic Biol Med; 2018 May; 119():115-120. PubMed ID: 29106991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.